Congratulations to Ningaloo Biosystems on Successfully Closing Their Financing Round

We extend our heartfelt congratulations to Ningaloo Biosystems GmbH on successfully completing their financing round. With their groundbreaking optogenetic technology, Ningaloo is setting new standards in bioproduction and accelerating the development of complex biopharmaceuticals. The newly secured funds—provided by NRW.BANK, capacura, and additional private investors—will enable the company to further expand its solutions for preclinical and early clinical production phases. This marks a significant step toward more efficient, sustainable, and precisely controllable production processes.

We are impressed by Ningaloo’s vision to fundamentally transform biopharmaceutical manufacturing through real-time light-based control. As an innovative and forward-looking company, Ningaloo is making an important contribution to the development of novel therapeutics.

We are excited to accompany this journey and support such a visionary company during this pivotal growth phase.

Learn more about Ningaloo Biosystems GmbH: https://ningaloo.bio

‍